ICD-10 Coding for Small Cell Lung Cancer(C34.90, C34.90B, C34.90M)
Learn about ICD-10 coding for small cell lung cancer, including primary and metastatic site documentation, to ensure accurate billing and compliance.
Complete code families applicable to Small Cell Lung Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung | Use when the specific site and laterality of the lung cancer are not documented. |
|
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung | Use when the cancer is confirmed in the right lung. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSmall Cell Lung Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Small Cell Lung Cancer.
Failure to document metastatic sites
Impact
Clinical: Incomplete clinical picture., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement for metastatic treatment.
Mitigation
Ensure all imaging and pathology reports are reviewed., Include metastatic sites in clinical documentation.
Using unspecified codes when laterality is known
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases the accuracy of health records.
Mitigation
Document and code the specific laterality of the tumor.
Unspecified Coding
Impact
High risk of audits due to unspecified codes when specificity is available.
Mitigation
Ensure all documentation includes specific laterality and metastatic sites.